0001104659-20-072521.txt : 20200611
0001104659-20-072521.hdr.sgml : 20200611
20200611190110
ACCESSION NUMBER: 0001104659-20-072521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200609
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heyman Tomas J.
CENTRAL INDEX KEY: 0001814673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 20958386
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-06-09
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001814673
Heyman Tomas J.
C/O AKERO THERAPEUTICS, INC., 170
HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
25.04
2020-06-09
4
A
0
26000
0
D
2030-06-09
Common Stock
26000
26000
D
This option shall vest and become exercisable in 36 equal monthly installments, commencing on June 9, 2020.
/s/ Jonathan Young, attorney-in-fact
2020-06-11